TickerSparkInvestor Intelligence
TickerSparkInvestor Intelligence
Custom Reports
Stock Deep Dives · Free to Try
AI Analyst
Agentic Chat · Free to Try
Watchlist
Track Your Stocks · Free
Spark Charts
AI Technical Analysis · Free to Try
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio · Pro
My Portfolio
Brokerage Connected · Pro
Custom Reports
Stock Deep Dives
AI Analyst
Agentic Chat
Watchlist
Your Stocks & Notes
Spark Charts
AI Technical Analysis
Trade Tracker
AI-Managed Portfolio
My Portfolio
Brokerage Connected
Main Feed
Today's Market Intel
Stock Reports
AI Research Reports
Top Stocks
AI-Curated Stock Lists
Commentary
Opinionated Stock Takes
Stock Teasers
The Stock Behind the Promo
Trending Stocks
Today's Big Movers
Earnings Coverage
Flashes & Deep Dives
Macro Updates
Economy & Markets
IPO Calendar
Upcoming Listings
CommunityDashboard
Log inCreate Account
← Back to TickerSpark
▌Earnings Flash·August 5, 2026

Cencora, Inc. (COR) gains on earnings beats, up 3.2%

Cencora, Inc. (COR) gains 3.2% after posting earnings beats, lifting shares as investors react to stronger-than-expected quarterly results.

Earnings FlashCORHealthcareMedical - Distribution
By TickerSpark·August 5, 2026·2 min read
Cencora, Inc. (COR) gains on earnings beats, up 3.2%
▌Key Takeaway
Cencora, Inc. (COR) reported a solid earnings beat, posting $4.48 in EPS on $84.75 billion in revenue versus estimates of $4.35 and $84.31 billion. Shares rose 3.16% to $315.97 in regular trading as investors responded positively to the company’s continued execution and four-beat-in-five-quarter earnings pattern.

Cencora, Inc. (COR) Earnings Beat; Stock Gains 3.16%

Cencora, Inc. (COR) beat both EPS and revenue estimates, reporting $4.48 EPS on $84.75B revenue, while the stock gained 3.16% in regular-session trading to $315.97.

Key Numbers

  • EPS: $4.48 actual vs. $4.35 estimate, a beat.

§ Product

  • How It Works
  • Custom Reports
  • AI Analyst
  • Intel Dashboard
  • Spark Charts
  • Trade Tracker
  • My Portfolio
  • Plans

§ Research

  • Main Feed
  • Community
  • Stock Reports
  • Macro Updates
  • Blog

§ Company

  • About Us
  • Contact

§ Fine Print

  • Terms of Service
  • Privacy Policy
  • Full Disclaimer
  • Cookie Policy

Notice: All content and data on TickerSpark is for informational purposes only and does not constitute financial or investment advice. All investments involve risk. Please see our Full Disclaimer for more details.

© 2026 Maxwell Cyberlogic LLC

Not Investment Advice

Made in Delaware, USA

Revenue: $84.75B actual vs. $84.31B estimate, a beat.
  • Stock reaction: COR gained 3.16% in regular-session trading to $315.97, up from $306.28.
  • Earnings trend: COR beat EPS estimates in four of the last five quarters.
  • Trading activity: Session volume was 534,771 shares versus a 1,779,393 average.
  • The Beat Reasserts Cencora's Earnings Momentum

    The quarter's core signal is conversion. Cencora paired $84.75B in revenue with $4.48 in EPS, beating both estimates. That combination points to execution across the income statement, not just sales scale. The 3.16% regular-session gain supports that first market read, although volume was 534,771 shares versus a 1,779,393 average.

    COR's latest result also strengthens a five-quarter pattern. EPS beat estimates on Aug. 6, 2025, Nov. 5, 2025, Feb. 4, 2026, and Aug. 5, 2026. The lone miss came May 6, 2026, when EPS was $4.75 versus $4.82. That record gives the new beat more weight than a one-quarter surprise, while the May miss shows why consistency still matters.

    On the earnings call, focus on whether management ties the $84.75B revenue result to repeatable demand and maintains the EPS pattern after the May miss. The regular-session range of $311 to $326.99 shows active repricing, while the $315.97 close leaves the market's initial verdict positive. Durable follow-through depends on whether the call reinforces the five-quarter record.

    Get AI research on any stock

    Instant reports, daily intelligence, and an AI analyst in your pocket.

    Get Started →

    Bottom Line

    COR's $4.48 EPS and $84.75B revenue beats, paired with a 3.16% regular-session gain, make this a constructive checkpoint for investors tracking execution.

    Read the full COR research report
    ▌Common Questions

    Frequently asked questions

    +Did Cencora (COR) beat earnings this quarter?
    Yes. Cencora reported $4.48 in EPS versus the $4.35 estimate and $84.75 billion in revenue versus the $84.31 billion estimate. The stock rose 3.16% in regular-session trading to $315.97.
    +Why did Cencora stock go up after earnings?
    The stock gained because Cencora beat both profit and revenue expectations, which signaled strong execution across the business. Investors also viewed the result as part of a broader pattern, with COR beating EPS estimates in four of the last five quarters.
    +How did Cencora's revenue compare with estimates?
    Cencora reported $84.75 billion in revenue, slightly above the $84.31 billion consensus estimate. That revenue beat helped support the positive market reaction to the quarter.
    +What was Cencora's stock reaction after the earnings report?
    Cencora shares increased 3.16% during regular-session trading, closing at $315.97 after trading as high as $326.99. Volume was 534,771 shares, below the 1,779,393-share average.
    ▌The Daily Briefing · Free

    A new stock idea, every evening.

    One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.

    Daily market recap + weekly preview. One-click unsubscribe in every email.

    ▌The Full Report

    Want the full picture on COR?

    The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.

    Read the COR report →Get Full Access →

    Not ready to subscribe? ·

    ▌The Full Report

    Get the full COR research report

    • Analyst-grade deep dive
    • Charts, valuation, grades
    • Buy/sell price targets
    Read the COR report →
    ▌For Active Investors

    Smarter research, on every ticker

    • Daily market intelligence
    • On-demand stock analysis
    • AI analyst chat
    Get Full Access →

    Cancel anytime

    ▌The Daily Briefing · Free

    A new stock idea, every evening.

    One stock worth watching each weekday, free in your inbox.

    Daily market recap + weekly preview. One-click unsubscribe in every email.

    ▌More on COR

    More to read

    All articles
    Cencora, Inc. (COR) gains after deep earnings beat analysis
    COR

    Cencora, Inc. (COR) gains after deep earnings beat analysis

    Cencora, Inc. (COR) posted a clean earnings beat, with EPS and revenue topping estimates and shares gaining 3.41%. This deep-dive examines segment performance, margin drivers, updated guidance, and what the result says about the company’s operating momentum and valuation backdrop.

    Aug 5·7 min
    Cencora (COR): Specialty Growth and Margin Mix
    COR

    Cencora (COR): Specialty Growth and Margin Mix

    Cencora posted 7.5% adjusted EPS growth in Q2 and raised full-year guidance, with specialty pharmaceuticals and international healthcare driving the upside. Thin margins and higher debt keep the story balanced, but the stock still screens as a Buy.

    Aug 5·21 min
    Cencora, Inc. (COR) slumps on Q2 miss: deep earnings analysis
    COR

    Cencora, Inc. (COR) slumps on Q2 miss: deep earnings analysis

    Cencora, Inc. (COR) slumps after missing on EPS and revenue, but the full story goes beyond the headline. This deep-dive unpacks U.S. Healthcare Solutions pressure, international strength, margin shifts, and why raised EPS guidance couldn’t offset a revenue reset.

    May 7·11 min